New council launched to enhance clinical trials in Ireland
Ireland has inaugurated the Clinical Trials Advisory Council to transform its clinical research sector. The council, chaired by Professor Donal Brennan, aims to implement key reforms and improve patient access to innovative treatments nationwide.
Source:
Gov.ie / MerrionStreet
•
⏱️ 1 min read
The establishment of the Clinical Trials Advisory Council (CTAC) marks a significant advancement in reforming Ireland’s clinical trials landscape. The council held its inaugural meeting on 27 August 2026, bringing together a wide spectrum of expertise from patient representatives, healthcare providers, academia, industry, and government bodies.
Chaired by Professor Donal Brennan, the council is tasked with driving forward reforms identified in the National Clinical Trials Oversight Group’s final report, published in November 2025. Its priorities include creating flexible systems, enhancing public and patient engagement, fostering value and incentives, supporting workforce development, and promoting innovative technologies in clinical trials.
Minister for Health Jennifer Carroll MacNeill emphasised the government’s commitment to strengthening Ireland’s clinical trials ecosystem. She highlighted the council’s collaborative composition as crucial to delivering better health outcomes and expanding patient access to novel therapies. Professor Brennan expressed his dedication to implementing the blueprint’s recommendations to benefit patients, researchers, and the wider health system.
Chaired by Professor Donal Brennan, the council is tasked with driving forward reforms identified in the National Clinical Trials Oversight Group’s final report, published in November 2025. Its priorities include creating flexible systems, enhancing public and patient engagement, fostering value and incentives, supporting workforce development, and promoting innovative technologies in clinical trials.
Minister for Health Jennifer Carroll MacNeill emphasised the government’s commitment to strengthening Ireland’s clinical trials ecosystem. She highlighted the council’s collaborative composition as crucial to delivering better health outcomes and expanding patient access to novel therapies. Professor Brennan expressed his dedication to implementing the blueprint’s recommendations to benefit patients, researchers, and the wider health system.
0 views